RVTY
Revvity, Inc.
NYSEUSDEQUITY
DELAYED
Last price
124.72
▲ 0.59 (0.48%)
MARKET · —
Price
Open
124.13
Prev close
124.13
Day high
124.97
Day low
121.51
Volume
1.86M
Market cap
—
P/E (TTM)
—
52W range
81.22 – 124.97
Trailing performance
Returnvs SPY
1W
+6.77%
+8.1%
1M
+10.23%
+6.5%
3M
+30.79%
+27.7%
6M
+24.34%
+13.3%
YTD
+28.94%
+16.7%
1Y
+36.04%
+16.0%
3Y
+8.71%
-65.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
118.22
+5.50% from price
SMA 20
115.59
+7.93% from price
SMA 50
111.18
+12.21% from price
SMA 100
102.63
+21.52% from price
SMA 200
100.58
+24.03% from price
EMA 12
118.25
+5.48% from price
EMA 26
115.27
+8.20% from price
EMA 50
111.41
+11.95% from price
RSI (14)
68.6
Neutral
MACD (12,26,9)
2.98
Hist 0.70
ATR (14)
4.01
3.22% of price
Realised vol 30D
33.3%
Annualised
Bollinger upper
123.32
20, 2σ
Bollinger lower
107.86
20, 2σ
50 / 200 cross
Golden
111.18 vs 100.58
Trend bias
Above 200
+24.03%
Risk profile
Beta vs SPY
1.25
More volatile than market
Correlation to SPY
0.42
Loosely linked
Realised vol 30D
33.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-30.1%
Peak to trough
Max drawdown 5Y
-59.2%
Peak to trough
ATR 14
4.01
3.22% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs
Zacks · 9d ago
The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call
StockStory · 10d ago
Revvity (RVTY) Q2 2026 Earnings Call Transcript
Motley Fool · 11d ago
Revvity to Present at Upcoming Investor Conferences
Business Wire · 11d ago
Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia Testing
Business Wire · 12d ago
1 Profitable Stock on Our Buy List and 2 We Find Risky
StockStory · 12d ago
Revvity Q2 Earnings Call Highlights
MarketBeat · 14d ago
Does Revvity’s Q2 Beat, Higher Guidance and China Exit Alter the Bull Case for RVTY?
Simply Wall St. · 17d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.